NDC11 60505625605
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 60505-6256-05 | 60505-6256 |
| 60505-6256-5 | 60505-6256 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rivaroxaban | RIVAROXABAN | Apotex Corp. | e98f6d83-5172-97a1-ee41-5d7d1d8ba2fd | 2026-04-17 | Boxed warning, Warnings, Adverse reactions | 60505-6256-5 60505-6256 60505625605 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.